Goldman Sachs’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-57,207
| Closed | -$1.09M | – | 5859 |
|
|
2022
Q1 | $1.09M | Buy |
57,207
+50,292
| +727% | +$956K | ﹤0.01% | 4040 |
|
|
2021
Q4 | $123K | Sell |
6,915
-2,962
| -30% | -$52.7K | ﹤0.01% | 5168 |
|
|
2021
Q3 | $366K | Buy |
9,877
+4,258
| +76% | +$158K | ﹤0.01% | 4552 |
|
|
2021
Q2 | $334K | Sell |
5,619
-31,546
| -85% | -$1.88M | ﹤0.01% | 4644 |
|
|
2021
Q1 | $2.49M | Buy |
37,165
+14,149
| +61% | +$948K | ﹤0.01% | 3191 |
|
|
2020
Q4 | $1.39M | Sell |
23,016
-18,819
| -45% | -$1.14M | ﹤0.01% | 3274 |
|
|
2020
Q3 | $3.31M | Buy |
41,835
+32,153
| +332% | +$2.54M | ﹤0.01% | 2636 |
|
|
2020
Q2 | $605K | Buy |
9,682
+155
| +2% | +$9.69K | ﹤0.01% | 3496 |
|
|
2020
Q1 | $505K | Sell |
9,527
-9,387
| -50% | -$498K | ﹤0.01% | 3492 |
|
|
2019
Q4 | $2.29M | Buy |
18,914
+12,382
| +190% | +$1.5M | ﹤0.01% | 2858 |
|
|
2019
Q3 | $1.19M | Sell |
6,532
-3,226
| -33% | -$586K | ﹤0.01% | 3155 |
|
|
2019
Q2 | $1.27M | Sell |
9,758
-4,332
| -31% | -$563K | ﹤0.01% | 3038 |
|
|
2019
Q1 | $3.43M | Buy |
14,090
+4,138
| +42% | +$1.01M | ﹤0.01% | 2643 |
|
|
2018
Q4 | $1.9M | Sell |
9,952
-1,279
| -11% | -$244K | ﹤0.01% | 2822 |
|
|
2018
Q3 | $3.68M | Sell |
11,231
-2,093
| -16% | -$687K | ﹤0.01% | 2585 |
|
|
2018
Q2 | $4.16M | Buy |
13,324
+3,840
| +40% | +$1.2M | ﹤0.01% | 2486 |
|
|
2018
Q1 | $2.31M | Buy |
9,484
+344
| +4% | +$83.8K | ﹤0.01% | 2792 |
|
|
2017
Q4 | $2.76M | Buy |
9,140
+746
| +9% | +$225K | ﹤0.01% | 2652 |
|
|
2017
Q3 | $2.22M | Buy |
8,394
+1,398
| +20% | +$370K | ﹤0.01% | 2813 |
|
|
2017
Q2 | $1.84M | Sell |
6,996
-702
| -9% | -$185K | ﹤0.01% | 2853 |
|
|
2017
Q1 | $2.77M | Buy |
7,698
+3,695
| +92% | +$1.33M | ﹤0.01% | 2533 |
|
|
2016
Q4 | $1.16M | Buy |
4,003
+1,146
| +40% | +$331K | ﹤0.01% | 3014 |
|
|
2016
Q3 | $973K | Buy |
2,857
+1,108
| +63% | +$377K | ﹤0.01% | 3072 |
|
|
2016
Q2 | $743K | Sell |
1,749
-729
| -29% | -$310K | ﹤0.01% | 3108 |
|
|
2016
Q1 | $793K | Sell |
2,478
-3,461
| -58% | -$1.11M | ﹤0.01% | 2982 |
|
|
2015
Q4 | $3.08M | Sell |
5,939
-3,436
| -37% | -$1.78M | ﹤0.01% | 2305 |
|
|
2015
Q3 | $2.75M | Buy |
9,375
+7,084
| +309% | +$2.08M | ﹤0.01% | 2348 |
|
|
2015
Q2 | $900K | Sell |
2,291
-1,247
| -35% | -$490K | ﹤0.01% | 3009 |
|
|
2015
Q1 | $1.07M | Buy |
3,538
+2,787
| +371% | +$843K | ﹤0.01% | 2867 |
|
|
2014
Q4 | $167K | Sell |
751
-7,913
| -91% | -$1.76M | ﹤0.01% | 4068 |
|
|
2014
Q3 | $2.01M | Buy |
8,664
+8,224
| +1,869% | +$1.91M | ﹤0.01% | 2510 |
|
|
2014
Q2 | $97K | Sell |
440
-4,146
| -90% | -$914K | ﹤0.01% | 4192 |
|
|
2014
Q1 | $1.45M | Buy |
4,586
+248
| +6% | +$78.3K | ﹤0.01% | 2771 |
|
|
2013
Q4 | $1.13M | Buy |
4,338
+2,933
| +209% | +$764K | ﹤0.01% | 2990 |
|
|
2013
Q3 | $206K | Sell |
1,405
-2,423
| -63% | -$355K | ﹤0.01% | 3824 |
|
|
2013
Q2 | $580K | Buy |
+3,828
| New | +$580K | ﹤0.01% | 3079 |
|